Albert Einstein Healthcare Network: Clinical Trials

66 trials sponsored by Albert Einstein Healthcare Network, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

31 completed, 14 terminated, 10 withdrawn, 3 unknown. 42 Not applicable, 12 Phase 4, 4 Phase 3, 2 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable42Completed 22, Terminated 8, Withdrawn 5, Enrolling by invitation 2, Recruiting 2, Active not recruiting 1, Not yet recruiting 1, Unknown 1
Phase 412Completed 3, Terminated 3, Withdrawn 3, Unknown 2, Suspended 1
Phase 34Completed 2, Active not recruiting 1, Withdrawn 1
Phase 22Active not recruiting 1, Withdrawn 1
Early Phase 11Completed 1

Follow Albert Einstein Healthcare Network: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Semantic Context on Criterion-learning Naming Treatment in Aphasia
Criterion-learning practice - Aphasia
Not applicableNot yet recruitingAlbert Einstein Healthcare Network122026-08-012026-07-13
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment
Active Virtual Reality Treatment - Phantom Pain Following Amputation of Lower Limb, Amputation
Not applicableRecruitingAlbert Einstein Healthcare Network442025-06-162025-08-08
NIBS Therapy in Subacute Spinal Cord Injury
Active rTMS, sham rTMS - Traumatic Spinal Cord Injury, Tetraplegia/Tetraparesis
Not applicableEnrolling by invitationAlbert Einstein Healthcare Network202025-04-092025-04-30
Criterion-learning Based Naming Treatment in Aphasia
Criterion-learning practice - Aphasia
Not applicableCompletedAlbert Einstein Healthcare Network222024-10-152026-07-08
Dapagliflozin in the Prevention of Post-Coronary Angioplasty Acute Kidney Injury
Dapagliflozin 10mg Tab - Acute Kidney Injury, Percutaneous Coronary Intervention
Phase 4SuspendedAlbert Einstein Healthcare Network2502024-09-012024-07-31
Criterion-learning Naming Treatment For Addressing Comprehension Deficits in Aphasia
Criterion-learning practice - Aphasia
Not applicableEnrolling by invitationAlbert Einstein Healthcare Network202024-06-242026-07-13
Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton
Eksobionics Eksoskeleton NR - Parkinson Disease
Not applicableCompletedAlbert Einstein Healthcare Network132024-06-042026-09-30
GetUp&Go: A Randomized Controlled Trial of an Intervention to Enhance Physical Activity After TBI
GetUp&Go, GetUp&Go with 10-Week Delay - Traumatic Brain Injury
Not applicableRecruitingAlbert Einstein Healthcare Network702023-12-192025-03-20
Assessing an Animal-Assisted Treatment Program for Adults With Aphasia: The Persons With Aphasia Training Dogs Program
Persons with Aphasia Training Dogs Program - Aphasia
Not applicableCompletedAlbert Einstein Healthcare Network172023-03-302025-10-16
Role of Prophylactic Postoperative Antibiotics in HoLEP
Nitrofurantoin, Cephalexin, Sulfamethoxazole Trimethoprim Combination - Benign Prostatic Hyperplasia, Urinary Tract Infections
Phase 4WithdrawnBaylor Research Institute2023-03-012026-02-12
Speech Entrainment Treatment for People With Aphasia
Audiovisual Speech Entrainment Practice, Auditory Speech Entrainment Practice - Aphasia, Acquired
Not applicableCompletedAlbert Einstein Healthcare Network302023-01-252025-09-18
Motor Learning After Cerebellar Damage: The Role of the Primary Motor Cortex
Transcranial Magnetic Stimulation (TMS) - Cerebellar Ataxia
Not applicableActive not recruitingAlbert Einstein Healthcare Network172022-07-012025-09-15
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain
VR treatment for phantom limb pain - Phantom Limb Pain
Not applicableCompletedAlbert Einstein Healthcare Network462022-05-102026-09-30
Bridging ED to Outpatient AUD Therapy With Naltrexone
Naltrexone Pill - Alcohol Use Disorder
Phase 4UnknownAlbert Einstein Healthcare Network202022-03-012022-02-08
Cesarean Section Skin Prep - Does Skin Preparation Pattern Affect Skin Bacterial Burden
Skin preparation patterns with ChloraPrep 2 x 26 mL single - Cesarean Section Complications, Wound Infection
Not applicableUnknownAlbert Einstein Healthcare Network1002021-02-022023-01-31
Aesthetic Effect of Steri-Strip Orientation on Healing and Scar Appearance in Breast Surgery
Steri-strip - Scar, Breast Neoplasms
Not applicableCompletedAlbert Einstein Healthcare Network942020-11-012023-08-14
A Study to Evaluate Efficacy and Safety of Denosumab for Prevention and Treatment of Osteoporosis in 1st Time Liver Transplant Recipients.
Denosumab Injection, Placebos - Osteoporosis
Phase 2WithdrawnAlbert Einstein Healthcare Network2020-07-012020-06-26
Acute Low Back Pain in the Emergency Department Treated With Osteopathic Manipulative Treatment Versus NSAIDs
Ibuprofen, Osteopathic manipulative treatment - Low Back Pain
Phase 4UnknownAlbert Einstein Healthcare Network1742020-02-192022-11-07
Health Literacy Activation RCT Among the COPD Patients and Designated Support Dyad
Intervention - COPD Exacerbation
Not applicableTerminatedAlbert Einstein Healthcare Network62019-06-152020-09-10
Perceptual-motor Interaction to Improve Bimanual Coordination After Stroke
Perceptual cuing - Stroke
Early Phase 1CompletedAlbert Einstein Healthcare Network792019-04-192025-08-14

Showing 20 of 66. Sign in to see all of them.

Conditions studied

Aphasia (5)  ·  Heart Failure (5)  ·  Brain Injuries, Traumatic (4)  ·  Abscess (3)  ·  Anomia (3)  ·  Brain Injuries (3)  ·  Communication Disorders (3)  ·  Sleep Apnea Syndromes (3)  ·  Acute Kidney Injury (2)  ·  Craniocerebral Trauma (2)  ·  End Stage Liver Disease (2)  ·  Hypertension (2)  ·  Kidney Calculi (2)  ·  Low Back Pain (2)  ·  Migraine Disorders (2)

Interventions

Propofol (3)  ·  Nitrous Oxide (2)  ·  Oxygen (2)  ·  Standard of Care (2)  ·  Tamsulosin (2)  ·  silodosin (2)  ·  1,1,1,3,3-pentafluoropropane (1)  ·  Absorbent Pads (1)  ·  Acetaminophen (1)  ·  Anesthesia (1)  ·  Aspirin (1)  ·  Atorvastatin (1)  ·  Cephalexin (1)  ·  Ciprofloxacin (1)  ·  Denosumab (1)

Countries

United States (61)  ·  Germany (1)

Top investigators

Darshak H Karia, MD (3)  ·  Darshak Karia, MD (3)  ·  James Gardner, MD (3)  ·  Amanda Rabinowitz, PhD (2)  ·  Catherine Anastasopoulou, MD, PhD (2)  ·  Erica L Middleton, PhD (2)  ·  Etienne J Phipps, PhD (2)  ·  Joseph Herres, DO (2)  ·  Kenneth Deitch, DO (2)  ·  Tessa Hart, PhD (2)  ·  Victor Navarro, MD (2)  ·  Adam Rowden, DO (1)  ·  Alberto Esquenazi, MD (1)  ·  Amanda S Therrien, PhD (1)  ·  Angelle Sander, PhD (1)

Results publications

PMID 11438246, PMID 22981809, PMID 26227484, PMID 26426636, PMID 27983582, PMID 28520666, PMID 30602590, PMID 30870102, PMID 31004141, PMID 31486722, PMID 31694576, PMID 32227142, PMID 35514131, PMID 3670870, PMID 41072740, PMID 41705067, PMID 41973444, PMID 6869117, PMID 6880820, PMID 8080219, PMID 8628042, PMID 9849105

NIH funding

R01DC015516 (3), R01HD104158 (2), P2CHD086844 (1), R01CA181191 (1), R01HD061400 (1), R01HD092481 (1), R03HD101146 (1), R21DC018893 (1)